David Gross
Overview
Explore the profile of David Gross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1005
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Semco R, McFall R, Khambhati J, Shah P, Gross D, Sobieszczyk P, et al.
JACC Case Rep
. 2024 May;
29(12):102371.
PMID: 38779554
Transcatheter aortic valve replacement may be performed with a transcarotid approach when peripheral vascular disease is prohibitive for transfemoral access. In this case, a patient who presented in cardiogenic shock...
2.
Nisman B, Oleinikov K, Nechushtan H, Maimon O, Atlan K, Peled N, et al.
J Thorac Oncol
. 2023 Oct;
18(11):e139-e141.
PMID: 37879775
No abstract available.
3.
Nisman B, Oleinikov K, Nechushtan H, Maimon O, Atlan K, Peled N, et al.
J Thorac Oncol
. 2022 Dec;
18(3):369-376.
PMID: 36503175
Introduction: The use of chromogranin A (CGA) as a circulating biomarker in lung carcinoids (LCs) is limited by low specificity and sensitivity. This study aimed to evaluate plasma progastrin-releasing peptide...
4.
Rossignol J, Belaid Z, Fouquet G, Guillem F, Rignault R, Milpied P, et al.
iScience
. 2022 Jul;
25(6):104353.
PMID: 35874918
Targeting immune checkpoints, such as Programmed cell Death 1 (PD1), has improved survival in cancer patients by restoring antitumor immune responses. Most patients, however, relapse or are refractory to immune...
5.
Chicheportiche A, Godefroy J, Krausz Y, Grozinsky-Glasberg S, Oleinikov K, Gross D, et al.
Harefuah
. 2021 Jul;
160(7):419-424.
PMID: 34263567
Aims: The aim of this study was to evaluate the predictive power of the absorbed dose to kidneys after the first course of treatment with [177Lu]-DOTA-TATE on the cumulative kidney...
6.
Kruse-Diehr A, Oliveri J, Vanderpool R, Katz M, Reiter P, Gray 2nd D, et al.
Implement Sci Commun
. 2021 May;
2(1):51.
PMID: 34011410
Background: Colorectal cancer (CRC) screening rates are lower in Appalachian regions of the United States than in non-Appalachian regions. Given the availability of various screening modalities, there is critical need...
7.
Kruse-Diehr A, Dignan M, Cromo M, Carman A, Rogers M, Gross D, et al.
J Cancer Educ
. 2021 Feb;
37(5):1407-1413.
PMID: 33599967
This study describes the development of a colorectal cancer (CRC) screening multilevel intervention with four primary care clinics in rural Appalachian Kentucky. We also discuss barriers experienced by the clinics...
8.
Delville M, Bellier F, Leon J, Klifa R, Lizot S, Vincon H, et al.
Blood
. 2021 Feb;
137(17):2326-2336.
PMID: 33545713
Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is caused by mutations in forkhead box P3 (FOXP3), which lead to the loss of function of regulatory T cells (Tregs) and the development...
9.
Stanifer S, Rayens M, Wiggins A, Gross D, Hahn E
J Rural Health
. 2020 Dec;
38(1):251-261.
PMID: 33382465
Purpose: This study compared differences in sociodemographic characteristics, personal risk perception of lung cancer, lung cancer worry, and synergistic risk perception among rural Appalachia residents who completed home radon testing...
10.
Gross D, Gumhold S
IEEE Trans Vis Comput Graph
. 2020 Oct;
27(2):614-624.
PMID: 33026996
3D Lines are a widespread rendering primitive for the visualization of data from research fields like fluid dynamics or fiber tractography. Global illumination effects and transparent rendering improve the perception...